A1AKM
N-[4-fluoro-5-({(2S,4S)-2-methyl-4-[(5-methyl-1,2,4-oxadiazol-3-yl)methoxy]piperidin-1-yl}methyl)-1,3-thiazol-2-yl]acetamide
| Created: | 2024-04-04 |
| Last modified: | 2025-01-15 |
Find Related PDB Entry |
|---|
Find related ligands: |
|---|
Chemical Details | |
|---|---|
| Formal Charge | 0 |
| Atom Count | 48 |
| Chiral Atom Count | 2 |
| Bond Count | 50 |
| Aromatic Bond Count | 10 |
Chemical Component Summary | |
|---|---|
| Name | N-[4-fluoro-5-({(2S,4S)-2-methyl-4-[(5-methyl-1,2,4-oxadiazol-3-yl)methoxy]piperidin-1-yl}methyl)-1,3-thiazol-2-yl]acetamide |
| Systematic Name (OpenEye OEToolkits) | ~{N}-[4-fluoranyl-5-[[(2~{S},4~{S})-2-methyl-4-[(5-methyl-1,2,4-oxadiazol-3-yl)methoxy]piperidin-1-yl]methyl]-1,3-thiazol-2-yl]ethanamide |
| Formula | C16 H22 F N5 O3 S |
| Molecular Weight | 383.441 |
| Type | NON-POLYMER |
Chemical Descriptors | |||
|---|---|---|---|
| Type | Program | Version | Descriptor |
| SMILES | ACDLabs | 12.01 | Fc1nc(NC(=O)C)sc1CN1CCC(OCc2nc(C)on2)CC1C |
| SMILES | CACTVS | 3.385 | C[CH]1C[CH](CCN1Cc2sc(NC(C)=O)nc2F)OCc3noc(C)n3 |
| SMILES | OpenEye OEToolkits | 2.0.7 | Cc1nc(no1)COC2CCN(C(C2)C)Cc3c(nc(s3)NC(=O)C)F |
| Canonical SMILES | CACTVS | 3.385 | C[C@H]1C[C@H](CCN1Cc2sc(NC(C)=O)nc2F)OCc3noc(C)n3 |
| Canonical SMILES | OpenEye OEToolkits | 2.0.7 | Cc1nc(no1)CO[C@H]2CCN([C@H](C2)C)Cc3c(nc(s3)NC(=O)C)F |
| InChI | InChI | 1.06 | InChI=1S/C16H22FN5O3S/c1-9-6-12(24-8-14-19-11(3)25-21-14)4-5-22(9)7-13-15(17)20-16(26-13)18-10(2)23/h9,12H,4-8H2,1-3H3,(H,18,20,23)/t9-,12-/m0/s1 |
| InChIKey | InChI | 1.06 | FRVXHWNHGWUTQO-CABZTGNLSA-N |
Drug Info: DrugBank
DrugBank data are sourced from datasets licensed under a Creative Common's Attribution-NonCommercial 4.0 International License
| DrugBank ID | DB21591 |
|---|---|
| Name | Ceperognastat |
| Groups | investigational |
| Description | Ceperognastat is a small molecule drug. Ceperognastat is under investigation in clinical trial NCT05063539 (A Study of LY3372689 to Assess the Safety, Tolerability, and Efficacy in Participants With Alzheimer's Disease). Ceperognastat has a monoisotopic molecular weight of 383.14 Da. |
| Synonyms | Ceperognastat |
| CAS number | 2241514-56-5 |
Drug Targets
DrugBank data are sourced from datasets licensed under a Creative Common's Attribution-NonCommercial 4.0 International License
| Name | Target Sequence | Pharmacological Action | Actions |
|---|---|---|---|
| Protein O-GlcNAcase | MVQKESQATLEERESELSSNPAASAGASLEPPAAPAPGEDNPAGAGGAAV... | unknown | inhibitor |
Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison
T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS.
Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682
Related Resource References
| Resource Name | Reference |
|---|---|
| PubChem | 135260636 |
| ChEMBL | CHEMBL5095251 |
